It All Starts
with
Acorn developed THE WORLD’S FIRST STEM CELL PLATFORM DESIGNED TO COLLECT, PRESERVE, AND ENHANCE THE POTENTIAL OF HAIR FOLLICLE STEM CELLS FOR REGENERATIVE TREATMENTS today and tomorrow.
We’re at the Beginning of an Anti-Aging Revolution
A hundred years ago, medicine focused on treating symptoms. Today, we’re shifting toward regenerative solutions that restore and heal at the cellular level.
Acorn is at the forefront of this movement—helping people preserve their youngest, most potent cells for use in groundbreaking treatments.
Early studies on stem cells & tissue regeneration
1930-1950
The discovery of human pluripotent stem cells
1998
Exosome therapy & regenerative aesthetics gain traction
2010
First-to-market personalized secretome product
Today
1930-1950
1998
2010
Today
Unlocking the Full Potential of Your Cells
Today
Topical
Professional secretome treatments for topical aesthetic use
Medium Term
Injectable
Personalized injectables using expanded live cells for restorative applications
Long Term
Advanced Medical Treatments
Advanced therapies with reprogrammed patient cells for regenerative medicine
As of December 2024
The Future is Bright
Active cell and gene-based clinical trials worldwide
Phase III clinical trials on regenerative therapies currently underway
Cell therapies approved globally
Backed by a Team of Scientists
ACORN was founded in 2017 by Dr. Drew Taylor, who unlocked the incredible potential of hair follicle stem cells during his PhD research at the University of Toronto. Acorn team brings together leading scientists, physicians, and lab experts dedicated to advancing regenerative medicine through cutting-edge work in Natural Killer cells, cartilage repair, organoid formation, and next-generation cell therapies.
In Partnership with Leading Research Institutions
